shutterstock_501493168_photolona

photolona / Shutterstock.com

19 January 2023GenericsLiz Hockley

Jazz Pharma’s medical cannabis unit seeks to block generic

UK-based cannabidiol lab sues firms behind proposed ANDA | Feud centres on a cannabis treatment for epilepsy.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

English High Court denies Jazz units’ jurisdictional challenge

4 May 2022 Two subsidiaries of Ireland-based Jazz Pharmaceuticals have failed in their bid to challenge the jurisdiction of the English High Court in a dispute with Tokyo-headquartered Otsuka Pharmaceutical over a cannabis sativa collaboration.

Jazz Pharmaceuticals acquires UK medical cannabis firm for $7.2bn

4 February 2021 Jazz Pharmaceuticals has acquired UK medicinal cannabis company GW Pharmaceuticals in a takeover worth $7.2 billion.

Jazz Pharma loses patent case over narcolepsy drug

28 February 2023 Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel.

More on this story

English High Court denies Jazz units’ jurisdictional challenge

4 May 2022 Two subsidiaries of Ireland-based Jazz Pharmaceuticals have failed in their bid to challenge the jurisdiction of the English High Court in a dispute with Tokyo-headquartered Otsuka Pharmaceutical over a cannabis sativa collaboration.

Jazz Pharmaceuticals acquires UK medical cannabis firm for $7.2bn

4 February 2021 Jazz Pharmaceuticals has acquired UK medicinal cannabis company GW Pharmaceuticals in a takeover worth $7.2 billion.

Jazz Pharma loses patent case over narcolepsy drug

28 February 2023 Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel.

More on this story

English High Court denies Jazz units’ jurisdictional challenge

4 May 2022 Two subsidiaries of Ireland-based Jazz Pharmaceuticals have failed in their bid to challenge the jurisdiction of the English High Court in a dispute with Tokyo-headquartered Otsuka Pharmaceutical over a cannabis sativa collaboration.

Jazz Pharmaceuticals acquires UK medical cannabis firm for $7.2bn

4 February 2021 Jazz Pharmaceuticals has acquired UK medicinal cannabis company GW Pharmaceuticals in a takeover worth $7.2 billion.

Jazz Pharma loses patent case over narcolepsy drug

28 February 2023 Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel.

More features

President Trump 2.0: Five major areas to watch

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?